The increase in price target by a reputable analyst like Michael Ulz from Morgan Stanley suggests a strong bullish outlook on Alpine Immune Sciences. This is likely to instill confidence among investors and could lead to a short-term increase in the stock price, as market participants often react positively to such upward revisions in price targets by prominent financial institutions.